<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate endoscopic mucosal resection (EMR) in patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) and/or intramucosal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (IMC) in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Between June 2000 and December 2003, 39 consecutive patients with HGD (35) and/or IMC (4) underwent EMR </plain></SENT>
<SENT sid="2" pm="."><plain>BE &gt;30 mm was present in 27 patients </plain></SENT>
<SENT sid="3" pm="."><plain>In three patients with short segment BE (25.0%), HGD was detected in a <z:mpath ids='MPATH_458'>normal</z:mpath> appearing BE </plain></SENT>
<SENT sid="4" pm="."><plain>Lesions had a mean diameter of 14.8+/-10.3 mm </plain></SENT>
<SENT sid="5" pm="."><plain>Mucosal resection was carried out using the cap method </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The average size of resections was 19.7+/-9.4 x 14.6+/-8.2 mm </plain></SENT>
<SENT sid="7" pm="."><plain>Histopathologic assessment post-resection revealed 5 low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (LGD) (12.8%), 27 HGD (69.2%), 2 IMC (5.1%), and 5 SMC (-12.8%) </plain></SENT>
<SENT sid="8" pm="."><plain>EMR changed the pre-treatment diagnosis in 10 patients (25.6%) </plain></SENT>
<SENT sid="9" pm="."><plain>Three patients with SMC underwent surgery </plain></SENT>
<SENT sid="10" pm="."><plain>Histology of the surgical specimen revealed 1 T0N0 and 2 T1N0 lesions </plain></SENT>
<SENT sid="11" pm="."><plain>The remaining two patients were <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> free at 32.5 and 45.6 mo, respectively </plain></SENT>
<SENT sid="12" pm="."><plain>A metachronous lesion was detected after 25 mo in one patient with HGD </plain></SENT>
<SENT sid="13" pm="."><plain>Intra-procedural <z:mp ids='MP_0001914'>bleeding</z:mp>, controlled at endoscopy, occurred in four patients (10.3%) </plain></SENT>
<SENT sid="14" pm="."><plain>After a median follow-up of 34.9 mo, <z:hpo ids='HP_0000001'>all</z:hpo> patients remained in remission </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSION: In the medium term, EMR is effective and safe to treat HGD and/or IMC within BE and is a valuable staging method </plain></SENT>
<SENT sid="16" pm="."><plain>It could become an alternative to surgery </plain></SENT>
</text></document>